Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Optics Letters
|
April 14, 2018
Quadratic nonlinear optical properties of the organic N-benzyl-2-methyl-4-nitroaniline (BNA) biaxial crystal
Cyril Bernerd, Patricia Segonds, Jérôme Debray, et al.
Optics Letters
|
November 4, 2025
Tunable single-frequency cascaded Stokes order generation in monolithic diamond Raman resonators
Cyril Bernerd, Georgios Stoikos, Katerina Chrysalidis, et al.
Scientific Reports
|
July 2, 2025
Quantification of trace <sup>227</sup>Ac and other radionuclidic impurities in mass-separated <sup>225</sup>Ac samples produced at CERN-MEDICIS
Jake D Johnson, Cyril Bernerd, Frank Bruchertseifer, et al.
Pharmaceutics
|
December 23, 2022
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [<sup>153</sup>Sm]Sm-DOTA-TATE
Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 28, 2024
Target Development towards First Production of High-Molar- Activity <sup>44g</sup>Sc and <sup>47</sup>Sc by Mass Separation at CERN-MEDICIS
Edgars Mamis, Charlotte Duchemin, Valentina Berlin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Optics Letters
|
April 14, 2018
Quadratic nonlinear optical properties of the organic N-benzyl-2-methyl-4-nitroaniline (BNA) biaxial crystal
Cyril Bernerd, Patricia Segonds, Jérôme Debray, et al.
Optics Letters
|
November 4, 2025
Tunable single-frequency cascaded Stokes order generation in monolithic diamond Raman resonators
Cyril Bernerd, Georgios Stoikos, Katerina Chrysalidis, et al.
Scientific Reports
|
July 2, 2025
Quantification of trace <sup>227</sup>Ac and other radionuclidic impurities in mass-separated <sup>225</sup>Ac samples produced at CERN-MEDICIS
Jake D Johnson, Cyril Bernerd, Frank Bruchertseifer, et al.
Pharmaceutics
|
December 23, 2022
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [<sup>153</sup>Sm]Sm-DOTA-TATE
Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 28, 2024
Target Development towards First Production of High-Molar- Activity <sup>44g</sup>Sc and <sup>47</sup>Sc by Mass Separation at CERN-MEDICIS
Edgars Mamis, Charlotte Duchemin, Valentina Berlin, et al.
Page
of 1